drugset

drugset / Trial / NCT00821002

A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

NCT00821002 ↗

Phase 2 Completed 32 enrolled Mati Therapeutics Inc. QLT Inc. · collab

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).

Timeline

Start: 2009-01
Primary completion: 2009-11
Completion: 2009-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Latanoprost	Small molecule	—	—

Indications